Lisata Therapeutics, Inc. (LSTA)

Lisata Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-20.05	-20.84	-54.23	-27.47	-8.15	-19.36
Depreciation & Amortization	0.19	0.19	0.07	0.06	0.06	0.07
Loss (Gain) From Sale of Assets	-	0	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	30.39	-	-	-
Loss (Gain) From Sale of Investments	-0.95	-0.96	0.79	2.51	0.31	0.23
Loss (Gain) on Equity Investments	0.1	-	-	-	-	-
Stock-Based Compensation	1.82	2.04	2.64	2.01	1.27	1.3
Other Operating Activities	-	-	-	-	0.01	0.01
Change in Accounts Payable	-0.07	0.09	-0.22	1.25	-2.84	-1.86
Change in Other Net Operating Assets	0.1	-0.55	-0.61	-0.6	0.52	0.74
Operating Cash Flow	-18.86	-20.03	-21.17	-22.25	-8.82	-18.88
Capital Expenditures	-	-	-0.29	-0.06	-0.02	-
Cash Acquisitions	-	-	-3.32	-	-	-
Investment in Securities	12.25	10.1	32.52	-54.84	-7.26	21.43
Investing Cash Flow	12.25	10.1	28.91	-54.9	-7.28	21.43
Issuance of Common Stock	0.48	0.48	0.04	85.52	18.73	1.31
Repurchase of Common Stock	-0.15	-0.09	-0.27	-0.25	-0.15	-0.13
Financing Cash Flow	0.33	0.39	-0.22	85.28	18.58	1.18
Foreign Exchange Rate Adjustments	-0.06	-0.02	-0.01	-	-	-
Net Cash Flow	-6.35	-9.56	7.51	8.14	2.48	3.73
Free Cash Flow	-18.86	-20.03	-21.46	-22.31	-8.84	-18.88
Free Cash Flow Per Share	-2.31	-2.48	-4.14	-6.05	-8.59	-27.43
Levered Free Cash Flow	-13.89	-14.36	-14.11	-15.45	-13.09	-10.96
Unlevered Free Cash Flow	-13.89	-14.36	-14.11	-15.45	-13.09	-10.96
Change in Net Working Capital	-0.02	0.52	-0.47	-0.7	2.43	-0.24

Source: S&P Capital IQ. Standard template.